Neotropix, Inc. Announces Presentation of Relevant Preclinical Results of NTX-010 in Pediatric Oncology Models
10/22/2008 8:44:52 AM
More...
|
Neotropix, Inc. Announces Expansion of On-Going Clinical Trial for Adult Neuroendocrine Cancers
10/8/2008 8:36:45 AM
More...
|
Neotropix, Inc. Appoints Anthony Williams, M.D., As Its Chief Medical Officer
9/23/2008 10:39:22 AM
More...
|
Neotropix, Inc. Receives FDA Approval To Begin Clinical Trials With First Investigational Cancer Drug
5/17/2006 11:20:23 AM
More...
|
Neotropix, Inc. Attracts $10 Million Series A Round For Development Of Novel Virotherapies To Treat Cancer
10/19/2005 5:12:26 PM
More...
|